This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Semaglutide — the active ingredient in the brand-name meds Ozempic, Wegovy, and Rybelsus — treats type 2 diabetes and obesity or ...
Simon Spichak finished his MSc at University College Cork, where he studied the interactions between the microbes in the gut and the brain. He became interested in science communication during his ...
Semaglutide is an injectable drug formulated for the treatment of type 2 diabetes, but it’s since become increasingly popular ...
Tirzepatide and semaglutide are popular weight loss drugs. Learn how they differ in effectiveness, cost, and side effects.
Stacker on MSN
GLP-1 side effects: What 400,000 patient reports reveal
Doctronic reports new AI analysis reveals GLP-1 medications may cause underreported symptoms like menstrual irregularities and fatigue.
Newspoint on MSN
Wegovy side effects: Those taking slimming pills should be careful, as they may lose their eyesight forever
Eye Disease Risk: GLP-1 drugs were first developed to treat type 2 diabetes, but are now increasingly being used to reduce obesity. Can weight loss medication cause loss of eyesight? Eye Problems ...
People who took semaglutide over a slower, more flexible schedule were significantly less likely to experience nausea and to discontinue use. Reading time 2 minutes Semaglutide’s ability to help ...
In a sweeping analysis of more than 400,000 Reddit posts, researchers have revealed some little-known GLP-1 side effects. GLP-1 receptor agonists — such as semaglutide (Ozempic and Wegovy), and ...
Share on Pinterest Semaglutide drugs aid weight loss and heart health but does that come at the expense of gut health? Image credit: Douglas Cliff/Getty Images. Diabetes medications based on ...
Semaglutide — the active ingredient in the brand-name meds Ozempic, Wegovy, and Rybelsus — treats type 2 diabetes and obesity or overweight. If you’ve recently been prescribed this medication or are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results